EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis

Takashi Yokoi, Takayasu Kurata, Yoshitaro Torii, Yuichi Katashiba, Makoto Ogata, Naoko Murakami Satsutani, Maiko Niki, Noriko Inagaki Katashiba, Kayoko Nishimura Kibata, Shosaku Nomura

Advances in Lung Cancer · 2015

DOI: 10.4236/alc.2015.41002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Lung Cancer, 2015. Verfasst von Takashi Yokoi und 9 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yokoi, T., Kurata, T., Torii, Y., Katashiba, Y., Ogata, M., Satsutani, N. M., Niki, M., Katashiba, N. I., Kibata, K. N., & Nomura, S. (2015). Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis. Advances in Lung Cancer. https://doi.org/10.4236/alc.2015.41002

Vancouver

Yokoi T, Kurata T, Torii Y, Katashiba Y, Ogata M, Satsutani NM, et al. Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis. Advances in Lung Cancer. 2015. doi:10.4236/alc.2015.41002

BibTeX
@article{Yokoi2015,
  author = {Yokoi, Takashi and Kurata, Takayasu and Torii, Yoshitaro and Katashiba, Yuichi and Ogata, Makoto and Satsutani, Naoko Murakami and Niki, Maiko and Katashiba, Noriko Inagaki and Kibata, Kayoko Nishimura and Nomura, Shosaku},
  title = {Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis},
  journal = {Advances in Lung Cancer},
  year = {2015},
  doi = {10.4236/alc.2015.41002}
}
Kostenlos starten →